UBS Oncology Impact Fund L.P. 13D/13G Filings for MEI Pharma, Inc. (MEIP)

UBS Oncology Impact Fund L.P. 13D and 13G filings for MEI Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
4:04 pm
Sale		 2022-12-31 13G MEI Pharma, Inc.
MEIP		 UBS Oncology Impact Fund L.P. 0
0.000%		 -506,893decrease
(Position Closed)		 Filing
2021-02-16
08:32 am
Purchase		 2020-12-31 13G MEI Pharma, Inc.
MEIP		 UBS Oncology Impact Fund L.P. 506,893
9.000%		 194,393increase
(+62.21%)		 Filing